Back to News
Feb 11, 2026 4:01 PM

Uncovering Potential: Karyopharm Therapeutics's Earnings Preview

Karyopharm Therapeutics (NASDAQ:KPTI) will release its quarterly earnings report on Thursday, 2026-02-12. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Karyopharm Therapeutics to report an earnings per share (EPS) of $-2.10.

The market awaits Karyopharm Therapeutics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors to understand that guidance can be a significant driver of stock prices.

Overview of Past Earnings

The company's EPS missed by $0.55 in the last ...